Skip to Main Content

+

  • • 5% overall survival

    • Risk factors

    • -Gallstones (70-90% of patients have gallstones)

      -Native American heritage

      -Stones > 3 cm (10-fold increased risk)

      -Porcelain gallbladder (at least 25% develop cancer)

      -Choledochal cyst

      -Gallbladder adenoma > 1 cm

    • 0.5% of patients with cholelithiasis have adenocarcinoma

    • 1% of patients undergoing elective cholecystectomy have unsuspected adenocarcinoma identified

    • Only 25% of patients have chance for curative resection

++

Epidemiology

+

  • • 6000-7000 cases annually

    • 3:1 female:male ratio

    • Peak incidence in seventh decade

    • Risk is at least 5% among Native Americans who have gallstones

++

Symptoms and Signs

+

  • • Biliary colic or cholecystitis

    • Jaundice

    • Weight loss

    • Anorexia

    • Palpable right upper quadrant mass

    • Hepatomegaly

    • Ascites

++

Laboratory Findings

+

  • • Leukocytosis

    • Hyperbilirubinemia

    • Elevated alkaline phosphatase

    • Elevated transaminases

    • Elevated carcinoembryonic antigen (CEA)

++

Imaging Findings

+

  • Right upper quadrant US

    • -Gallbladder inflammation and/or gallstones

      -Occasional gallbladder mass

      -Portal or cystic lymphadenopathy

      -Dilated common bile duct (CBD)

      -Direct tumor extension into liver

    CT or MRI

    • -Gallbladder mass (90% sensitive) with occasional portal lymphadenopathy

      -Hepatic extension of tumor

    ERCP or percutaneous transhepatic cholangiogram (PTC)

    • -Intraluminal gallbladder mass

      -Occasional CBD dilatation

      -Intraluminal extension of tumor

+

  • • Lymph node involvement

    • Extension into extrahepatic biliary tree

    • Extension into hepatic parenchyma

+

  • • History and physical exam

    • CBC

    • Liver function tests

    • Right upper quadrant US

    • Abdominal CT or MRI

    • CEA level

++

Surgery

+

  • • Cholecystectomy (T1 tumors—limited to muscular wall)

    • Cholecystectomy with segment 4b, 5 liver resection and portal lymphadenectomy (T2 tumors—invasion to perimuscular tissue but not to serosa)

    • Right extended hepatectomy (for some T3 and T4s and recurrence after cholecystectomy or 4b, 5 segmental resection)

    • Right extended hepatectomy and resection of CBD followed by hepaticojejunostomy for invasion into CBD

++

Treatment Monitoring

+

  • • CEA levels

    • US or CT scanning

++

Complications

+

  • • Biliary leak or injury

    • Anastomotic leak or stricture

    • Liver failure

    • Perihepatic infection

    • Disease recurrence

++

Prognosis

+

  • • 5-year survival with resection for curative intent, 17%

    • > 95% survival for T1 tumors treated with cholecystectomy

    • Range from 70% to > 90% for T2 and T3 if 4b and 5 segment resections performed and no nodal involvement

++

References

Kondo S et al. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg. 2000;87:418.  [PubMed: 10759735]

++

Practice Guidelines

+

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessSurgery Full Site: One-Year Subscription

Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessSurgery

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.